Tower View Wealth Management LLC lessened its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 11.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,448 shares of the company’s stock after selling 931 shares during the period. Tower View Wealth Management LLC’s holdings in Procter & Gamble were worth $1,290,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of the business. Steele Capital Management Inc. purchased a new stake in shares of Procter & Gamble during the first quarter worth about $204,000. GAMMA Investing LLC increased its stake in Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares in the last quarter. Consilio Wealth Advisors LLC lifted its position in shares of Procter & Gamble by 27.7% in the first quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock valued at $283,000 after acquiring an additional 379 shares in the last quarter. AMF Tjanstepension AB boosted its stake in shares of Procter & Gamble by 416.1% in the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after acquiring an additional 1,466,115 shares during the last quarter. Finally, Talbot Financial LLC increased its position in shares of Procter & Gamble by 1.5% during the first quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock worth $10,644,000 after purchasing an additional 950 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
NYSE PG opened at $169.43 on Monday. The stock has a 50-day moving average of $171.93 and a two-hundred day moving average of $167.69. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The company has a market cap of $399.88 billion, a P/E ratio of 27.49, a P/E/G ratio of 3.67 and a beta of 0.41.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.38%. Procter & Gamble’s payout ratio is 65.69%.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Jon R. Moeller sold 72,174 shares of the firm’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the sale, the chief executive officer now owns 263,158 shares in the company, valued at approximately $45,002,649.58. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 397,986 shares of company stock valued at $67,642,430 over the last 90 days. 0.17% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Several brokerages have issued reports on PG. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a research note on Monday, September 30th. TD Cowen assumed coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Thursday, August 29th. Finally, Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Nine analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $177.00.
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
- 5 Top Rated Dividend Stocks to Consider
- Alphabet’s Earnings Could Surprise—Should You Buy Now?
- How to buy stock: A step-by-step guide for beginners
- MaxLinear: Staging a Turnaround for the AI Broadband Chip Maker
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.